MDMA-maker failed its FDA hearing — and its PTSD patients
by Lisa Jarvis What could have been a huge moment in psychedelics’ quest for medical legitimacy was instead a major misstep for the field. Last week, the Food and Drug Administration’s expert advisers sent a strong message that Lykos Therapeutics Inc.’s MDMA-assisted therapy for ...